|
|
| | 2-(4-Cyclopropyl-6-methoxy-5-pyrimidinyl)-7-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine Basic information |
| | 2-(4-Cyclopropyl-6-methoxy-5-pyrimidinyl)-7-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine Chemical Properties |
| density | 1.49±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 12.17±0.40(Predicted) | | form | Solid | | color | White to off-white |
| | 2-(4-Cyclopropyl-6-methoxy-5-pyrimidinyl)-7-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine Usage And Synthesis |
| Uses | TNG-0746132 can be used for synthesis of the compound with anticancer activity[1]. | | References | [1] Throner Scott, et al. Preparation of pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer. World Intellectual Property Organization, WO2022174184 A1. 2022-08-18. |
| | 2-(4-Cyclopropyl-6-methoxy-5-pyrimidinyl)-7-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine Preparation Products And Raw materials |
|